FDA Alerts
FDA Warns Against Diet Pill
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Botanical Slimming, a product promoted for weight loss. This product was identified by FDA during an examination of international mail shipments.
FDA Approves First Tissue Adhesive for Internal Use
The U.S. Food and Drug Administration (FDA) today approved TissuGlu, the first tissue adhesive approved for internal use.
Yanhee Slim Contains Hidden Drug Ingredient
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Yanhee Slim, a product promoted and sold for weight loss on various websites.
FDA to Strengthen Review of AEDs
The U.S. Food and Drug Administration announced today that it will strengthen its review of automated external defibrillators (AEDs) to help improve the quality and reliability of these devices.
B-Lipo Contains a Hidden Drug Ingredient
The Food and Drug Administration (FDA) is advising consumers not to purchase or use B-Lipo, a product promoted and sold for weight loss on various websites and in some retail stores.
Slim-K Contains Hidden Drug Ingredients
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Slim-K, a product promoted and sold for weight loss on various websites and in some retail stores.
FDA Approves First Pathogen Reduction System to Treat Plasma
The U.S. Food and Drug Administration today approved the Intercept Blood System for plasma, the first pathogen reduction system for use by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted infections (TTI).
Company Stops Operations Due to Repeated Food Safety Violations
William H. Oshiro, owner of RZM Food Factory, has agreed to stop processing and distributing food until he demonstrates to the FDA that RZM Food Factory’s facility and practices comply with federal food safety requirements.
FDA: Neptune Manufacturing Must Take Steps to Safely Produce Seafood
On December 1, a federal judge from the U.S. District Court for the Central District of California entered a consent decree of permanent injunction against Neptune Manufacturing, Inc., of Los Angeles, and its owners, Alexander Goldring, Peter Oyrekh and Semyon Krutovsky.
FDA Approves Rx for Bone Marrow Disease
The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.